- A collaborative study demonstrates that AI analysis of Tertiary Lymphoid Structures (TLS) in tumo...
- Collaborative study with NCCHE shows that AI analysis of HER2 expression and the tumor microenvir...
Lunit strengthens presence in the Middle East by supplying AI-powered breast screening solution to ...
* Lunit's AI-powered cancer screening solutions have been selected for Seha Virtual Hospital's AI...
- Recent study conducted by Seoul National University Hospital provides strong evidence that high-a...
- Medical AI solutions, including CXR-AID, officially included in Japanese health insurance reimbur...
- Lunit's pioneering AI study to be unveiled at one of the premier computer vision conferences, inn...
- Lunit and Sweden's largest private hospital pioneering a new approach to combine radiologists' ex...
* Collaborative research with Japan's largest oncology practice shows Lunit SCOPE's potential in ...
- New studies reveal Lunit SCOPE's impact on predicting clinical outcomes, analyzing tumor microenv...
- Lunit and collaborators demonstrate the predictive value and analytical prowess of Lunit's AI-bi...
* Lunit and collaborators demonstrate key progress in the development of novel diagnostics for ca...
* Lunit set to launch Lunit INSIGHT DBT in the European market * Lunit seeks FDA clearance, pavi...
* Five posters from Lunit and collaborators demonstrate important progress in the development of ...
* Lunit to establish new subsidiary, Lunit Europe Holdings, to expand sales network acrossEurope ...
* First-ever randomized controlled trial regarding deep learning-based AI in radiology provides s...
* Dubai Academic Health Corporation (DAHC) Dubai Hospital to modernize its Breast Cancer Diagnost...
* Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows...
* Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune ...
* Lunit signed a software license agreement with the Hospital Israelita Albert Einstein,Latin Ame...
